harisham74

harisham74 | Joined since 2020-09-01

Investing Experience Intermediate
Risk Profile Moderate

Followers

0

Following

1

Blog Posts

0

Threads

172

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
172
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2020-12-30 10:16 | Report Abuse

colecting piece by piece since September..before rm 1 mark

Stock

2020-12-30 10:15 | Report Abuse

collect more before March 2020

Stock

2020-12-30 10:13 | Report Abuse

last two day missing the boat...but today i sense renew interest or recovery of price from yesterday

Stock

2020-12-30 09:39 | Report Abuse

collection some more.. below 0.50

Stock

2020-12-29 10:18 | Report Abuse

technically still strong buy..

Stock

2020-12-29 09:42 | Report Abuse

recovering very fast

Stock

2020-12-29 09:39 | Report Abuse

time to grab cheap below 0.6

Stock
Stock

2020-12-24 19:03 | Report Abuse

Clinical trial phase 3 for any vaccine should be the critical phase to asses the adverse side effect the may arise..therefore..the move to use en mass before the phase 3 clinical trial end.will create much problem.

Stock

2020-12-24 11:00 | Report Abuse

Thanks @Albukhary

Stock

2020-12-24 10:44 | Report Abuse

0.165 and going strong...

Stock

2020-12-06 13:09 | Report Abuse

very vaccine jab need a pair of new glove... the glove still in play with lower note..

Stock

2020-12-04 15:14 | Report Abuse

murah2 get additional stocks to hold

Stock

2020-11-30 09:44 | Report Abuse

Phase III already started

The Chinese company CanSino Biologics developed a vaccine based on an adenovirus called Ad5, in partnership with the Institute of Biology at the country’s Academy of Military Medical Sciences. In May, they published promising results from a Phase 1 safety trial, and in July they reported that their Phase 2 trials demonstrated the vaccine produced a strong immune response. In an unprecedented move, the Chinese military approved the vaccine on June 25 for a year as a “specially needed drug.” CanSino would not say whether vaccination would be mandatory or optional for soldiers. Starting in August, CanSino began running Phase 3 trials in a number of countries, including Saudi Arabia, Pakistan and Russia.

Updated Sept. 24( New York Times)

Stock

2020-11-25 22:54 | Report Abuse

Solution the forunner in vaccine race..

Stock

2020-11-18 11:29 | Report Abuse

ASB hold so much...

Stock

2020-11-06 12:30 | Report Abuse

haiya.. sudah naik...

Stock

2020-09-17 12:35 | Report Abuse

not easy to manipulate ..

Stock

2020-09-14 11:02 | Report Abuse

my bet close at 0.24

Stock

2020-09-14 10:05 | Report Abuse

today close at 0.24 my bet

Stock

2020-09-08 11:35 | Report Abuse

dont worry..